CJC-1295 NO DAC + IPAMORELIN 20MG

CJC-1295 NO DAC + IPAMORELIN is a combination of two synthetic research compounds, containing 10MG CJC-1295 NO DAC and 10MG IPAMORELIN for a total strength of 20MG. Research has focused on their activity within growth hormone signaling pathways and their interactions with GHRH and ghrelin receptors.

Research Areas Include:

• Growth Hormone Signaling — Investigated for potential influence on pathways responsible for regulating endogenous growth hormone release.

• GHRH Receptor Activity — CJC-1295 NO DAC (10MG) is studied for its interaction with growth hormone-releasing hormone (GHRH) receptors.

• Ghrelin Receptor Activity — IPAMORELIN (10MG) is investigated for its activity at the growth hormone secretagogue receptor (GHS-R1a).

• IGF-1 Signaling — Research has examined downstream IGF-1 signaling associated with growth hormone pathways.

• Metabolic Research — Studied in experimental models examining pathways involved in energy utilization and metabolic regulation.

• Combined Signaling Research — The 10MG + 10MG formulation allows investigation of two distinct signaling mechanisms associated with growth hormone regulation.

Product: CJC-1295 NO DAC + IPAMORELIN

Total Strength: 20MG(CJC-1295 NO DAC: 10MG+IPAMORELIN: 10MG)

Brand: REV-LABS

PRECISION RESEARCH. RELENTLESS RESULTS.

For research use only. Not for human consumption.